Close
Smartlab Europe
Achema middle east

New study highlights strong anti-cancer properties of soybeans

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Teva, Royalty Pharma $500M Deal to Advance Autoimmune Drug

Teva Pharmaceutical Industries and Royalty Pharma have signed a...

Pierre Fabre, Iktos Launch AI-Driven Oncology Drug Discovery

An integrated partnership has been formed between Pierre Fabre...

Revvity and Lilly Expand Lilly TuneLab Access via Signals

Revvity, Inc. announced a collaboration with Eli Lilly and...
- Advertisement -

Soybean meal is a bi-product following oil extraction from soybean seeds. It is rich in protein, which usually makes up around 40% of the nutritional components of the seeds and dependent on the line, and can also contain high oleic acid (a monounsaturated omega-9 fatty acid).

The study looked at the role soybeans could have in the prevention of cancer. Using a variety of soybean lines which were high in oleic acid and protein, the researchers looked to monitor bioactivity between the peptides derived from the meals of soybean and various types of human cancer cells.

The study showed that peptides derived from soybean meal significantly inhibited cell growth by 73% for colon cancer, 70% for liver cancer and 68% for lung cancer cells using human cell lines. This shows that the selected high oleic acid soybean lines could have a potential nutraceutical affect in helping to reduce the growth of several types of cancer cells.

This article is “Peptides derived from high oleic acid soybean meals inhibit colon, liver and lung cancer cell growth” by Srinivas J. Rayaprolu, Navam S. Hettiarachchy, Pengyin Chen, Arvind Kannan and Andronikos Mauromostakos

 

Latest stories

Related stories

Teva, Royalty Pharma $500M Deal to Advance Autoimmune Drug

Teva Pharmaceutical Industries and Royalty Pharma have signed a...

Pierre Fabre, Iktos Launch AI-Driven Oncology Drug Discovery

An integrated partnership has been formed between Pierre Fabre...

Revvity and Lilly Expand Lilly TuneLab Access via Signals

Revvity, Inc. announced a collaboration with Eli Lilly and...

The Role of Therapy in Managing Chronic Stress and Trauma

Have you ever felt like you’re constantly tired, even...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »